Target intelligence / Profile preview

Glycan antigen

Molecular classification
Other
01

Overview

Glycan antigens are carbohydrate-containing structures found on the surface of cells and microorganisms, typically as part of glycoproteins or glycolipids, that are recognized by the immune system as non-self or altered-self, stimulating antibody or immune responses[1][6]. They are highly diverse, comprising both short and long oligosaccharide or polysaccharide chains with different linkages and modifications[5][7]. Human, plant, animal, and microbial cells all display different glycan structures; foreign or tumor-specific glycan epitopes can be immunogenic and serve as targets or biomarkers for immune surveillance, vaccines, or diagnostics[1][2][6]. Classic examples include blood group antigens, tumor-associated carbohydrate antigens (such as Sialyl Tn or Lewis antigens), and microbial polysaccharide capsules[3][6]. Because "glycan antigen" is not a unique molecular species, it cannot be categorized as a single drug target or receptor but refers to a structural motif class that includes many distinct molecules[1][2][7]. Key context: - "Glycan antigen" is a category rather than a specific, actionable molecular target[1][2][6][7]. - For structured data purposes, it is too broad and non-specific; specific glycan antigens, such as "Sialyl Tn antigen" or "Lewis Y antigen," would be appropriate molecules. - As such, "Glycan antigen" is not considered a unique therapeutic target, receptor, or enzyme in a structured pharmacological sense. If structured information on a specific glycan antigen or sub-type is needed, the query should be refined to a discrete entity, such as "Sialyl Tn antigen" or "Globo H antigen."

Other names
carbohydrate antigenglycan epitopecomplex carbohydrate antigenglycolipid antigenglycoprotein antigenpolysaccharide antigen
02

Biological functions

Immune responseCell recognitionCell adhesionOther
03

Disease associations

CancerInfectionInflammationOther
04

Safety considerations

Immunogenicity diversityautoimmunity riskoff-target effects due to broad tissue distribution
05

Biomarkers

CA19-9Sialyl-Lewis^aSialyl TnTn antigenLewis Y

Beyond the preview

Go deeper on Glycan antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycan antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call